Skip to main content

MoneyWorks4Me

Lupin informs about investor presentation

07 May 2024 Evaluate
Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Investor Presentation-Q4 FY24.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..